Home › Funds › Laurion Capital Management LP › NUVB

Laurion Capital Management LP position in NUVB

NUVATION BIO INC · Health Care

Laurion Capital Management LP reported holding 7,697,272 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$43.1M, representing 2.35% of its reported portfolio and ranking #10 among its reported holdings. Laurion Capital Management LP has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)7.70M sh
Reported value held$43.10M
Portfolio Weight2.35%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Laurion Capital Management LP's NUVB position evolved

Laurion Capital Management LP first disclosed a stake in NUVB in Q2 2024 at 1,591,475 shares (US$4.6M). The position peaked in Q4 2025 at 7,852,638 shares, worth US$70.4M. Across 10 filings, Laurion Capital Management LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 7,697,272 shares valued at US$43.1M — a reduction of -122,741 shares quarter over quarter.. Notable position changes include a 308% increase in Q4 2024 (shares fell 34% over the following quarter), a 52% increase in Q1 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.59M $4.65M New
Q3 2024 1.59M $3.64M Hold
Q4 2024 6.49M $17.27M Add
Q1 2025 9.87M $17.37M Add
Q2 2025 10.24M $19.97M Add
Q3 2025 9.71M $35.91M Reduce
Q4 2025 7.85M $70.36M Reduce
Q1 2026 7.82M $33.56M Hold
Q2 2026 7.82M $44.42M Hold
Q3 2026 7.70M $43.10M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Laurion Capital Management LP held NUVB?

Laurion Capital Management LP has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Laurion Capital Management LP's current position in NUVB?

As of Q3 2026, Laurion Capital Management LP holds 7.70M shares of NUVB (NUVATION BIO INC), valued at $43.10M, representing 2.35% of its reported portfolio and ranking #10.

Has Laurion Capital Management LP been buying or selling NUVB?

In the latest 13F filing (Q3 2026), Laurion Capital Management LP reduced its position in NUVB. The position peaked in Q4 2025 at 7.85M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Omega Fund Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.